“a slight trend”

A slight trend was observed with respect to VSOP which seems to improve the functional liver capacity in HBD and NHBD livers compared to 18 h of CS.

Although all treatment groups showed a slight trend toward increased strength, the results were not significant.

This confirmed that there were no significant reductions in SOR scores in this group, and the presence of a slight trend towards a reduction was similar in the placebo, B6 and B12 groups, rather than selective to B6.

In recent years, the combination regimen of gemcitabine and cisplatin (GC) has demonstrated equivalent efficacy as well as lower toxicity, and has become largely the regimen of choice, despite a slight trend toward greater efficacy with MVAC therapy [ 4 ].

The plot shows a slight trend in the differences between overground and treadmill cadence.

However, our study did not note a significant increase of DR, only a slight trend towards DR (HR = 1.17, 95% CI = 0.75–1.82).

With this simultaneous presentation, we observed a slight trend of time dilation with the supra-second duration, and a slight trend of time compression with the peri-second duration.

Thus, although there was a slight trend for increased agonistic behavior toward LPS-injected bees, there was no overall significant difference in the proportion of agonistic interactions between the three groups (Chi 2 = 2.132; df = 2; P > 0.344).

Of note, we only observed a slight trend for less pain on the device side, starting on day 3 (Fig. 3 ).

There was a slight trend of improvement in nutritional status.

Similarly, when tri-inoculated in magenta boxes, the wild type performed similarly to co-inoculation, but the mutants followed a slight trend based on the benefit provided.

A slight trend of initial overcorrection with values above 0 SPH D was noted, followed by slight undercorrection at 6 months and 1 year postoperatively.

We noted a high degree of correlation between expression levels detected in each annotation regardless of differences in 3' UTR lengths, although we still noted a slight trend of longer 3'UTRs displaying slightly higher expression ( Figure 2—figure supplement 2H , Figure 2—source data 3 ).

While there was a slight trend towards increased co-localization with four of these markers in co-cultures with LVS-immune lymphocytes, all co-localization levels were low.

Stat1 expression was not affected by mock treatment in DBA/2J mice, but there was a slight trend (statistically not significant) for up-regulation in C57BL/6J mice.

Decreased appetite (anorexia) showed a slight trend of increase with age (32%, 37%, and 42% in patients aged < 65, ≥ 65, and ≥ 75 years, respectively).

The DNA histogram results showed no significant change in cell cycle after 24 h treatment of SQ-diEG, but a slight trend of cell arrest was found in S phase (Fig. 1 D).

We were not able to document a significant influence of the first-line treatment in NET G3 patients on mOS, but there was a slight trend toward better survival with the use of STZ + FU (only used in pancreatic NET G3 patients) and temozolomide plus capecitabine as compared to platinum-containing combinations.

The effect on front squat was expected to be small, given the upper limits of performance, but it is noted that even a slight trend towards a greater 3RM may still be of practical importance. 2.

In advanced NSCLC patients, neither the tumor stage nor the grading were able to accurately identify cases at higher risk of early disease recurrence, although a slight trend toward statistical significance was obtained when grouping according to the tumor stage ( Supplementary Table S4 ).

Additionally, transwell invasion and migration assays revealed that OPN expression levels did not influence the invasion or migration of CRC cells, although there was a slight trend toward the opposite effect (Fig. 3C ).

In the phase IIB LUX-Lung 7 trial, Afatinib demonstrated superior progression-free survival (PFS) compared to first-generation Gefitinib in the first-line treatment of advanced NSCLC with EGFR mutations, along with a slight trend toward improved overall survival (OS) [ 15 , 16 ].

A slight trend toward higher weights (less down-weighting) performing better (positive delta performances) than lower weights can be observed.

So far, a slight trend towards enlarged DT costs in children compared with young adults can be assumed.

There is a slight trend that patients with intermediate or high IPSS risk had higher incidence of miR-124-3 high methylation, it did not reach the statistical significance (Table 4 ). miR-124 suppresses cell proliferation in the SKM-1 cell line We first examined the methylation status of miR-124-1, miR-124-2 and miR-124-3 in the SKM-1 cell line, and the results showed that methylation levels significantly decreased after DAC treatment (Fig. 3a ).